Association between volume of lung damage and endoplasmic reticulum stress expression among severe COVID-19 ICU patients
View abstract on PubMed
Summary
This summary is machine-generated.Endoplasmic reticulum stress (ERS) in severe COVID-19 patients is linked to lung damage volume (LDV). Systemic inflammation correlates with organ failure but not LDV, suggesting distinct pathways in COVID-19 severity.
Area Of Science
- Critical Care Medicine
- Pulmonology
- Pathophysiology
Background
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is linked to endoplasmic reticulum stress (ERS).
- The interplay between ERS, inflammation, and organ damage in COVID-19 patients remains unclear.
- Understanding these relationships is crucial for managing severe COVID-19 cases in intensive care units (ICUs).
Purpose Of The Study
- To investigate the association between ERS and lung damage volume (LDV) in severe COVID-19 ICU patients.
- To explore the relationship between systemic inflammation markers and organ failure.
- To determine if ERS explains LDV in this patient cohort.
Main Methods
- A single-center retrospective study analyzed severe COVID-19 ICU patients.
- Chest computed tomography (CT) scans assessed LDV within 24 hours of admission.
- Multivariate linear regression models identified factors associated with plasma levels of GRP78 (ERS marker) and IL-6 (inflammation marker).
Main Results
- Plasma GRP78 levels, an ERS marker, were significantly associated with LDV (p=0.0179 and p=0.0423).
- Plasma IL-6 levels, an inflammation marker, were associated with organ failure (SOFA score) (p<0.0001) but not LDV (p=0.3219).
- No correlation was found between GRP78 and IL-6 plasma levels (p=0.3106).
Conclusions
- Endoplasmic reticulum stress is associated with lung damage volume in severe COVID-19 patients.
- Systemic inflammation is linked to organ failure but not directly to lung damage volume.
- These findings suggest distinct pathophysiological roles for ERS and inflammation in COVID-19 severity.

